GLP-1 Receptor Agonists: Metabolic Regulators GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda), suppress appetite, enhance insulin sensitivity, and promote weight loss by mimicking the incretin hormone GLP-1
Rotating to the abdomen every third day maintains therapeutic effect while giving local tissue a rest
It can change within days
In 2023, the FDA placed approximately 1719 peptides on the Category 2 restricted list citing safety concerns: potential carcinogenicity, immunogenicity risk, organ toxicity, and a lack of clinical trial data in humans
This deficiency is often found in vegetarian people
Possible biological benefits under investigation include: Reduced energy intake Altered satiety signaling Modulation of body weight-related outcomes How does Cagrilintide (10mg) work in research studies